Ross Kedl, PhD

Professor of Immunology & Microbiology
University of Colorado

Ross KedlDr. Kedl received his PhD in 1997 in the Department of Laboratory Medicine and Pathology at the University of Minnesota in Minneapolis. Before joining the Faculty at the University of Colorado, Dr. Kedl was at 3M Pharmaceuticals working in their small molecule immune response modifier program. In his three years there, he spearheaded efforts at developing novel vaccine adjuvants, resulting in numerous publications and patents in the area of vaccine technology. Dr. Kedl returned to the academic sector in 2004 by joining the faculty in the Integrated Department of Immunology at the University of Colorado Health Sciences Center and National Jewish Medical Research Center where he continues to pursue the discovery and development of novel and clinically applicable vaccine technology. He is also the founder of a start-up pharmaceutical company, ImmuRx Inc., which focuses on developing therapeutic vaccines against chronic infectious diseases, such as HIV and cancer.

Biography from University of Colorado.

IDIGH Calendar

<<  <  January 2019  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
   1  2  3  4  5  6
  7  810111213
141517181920
212224252627
282931   

Upcoming Events

Latest IDIGH Publications

  1. Bérard, A., Sheehy, O., Zhao, J.-P., Gorgui, J., Bernatsky, S., de Moura, C. S. & Abrahamowicz, M.
    (2019)
    .
    Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies
    .
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
    ,
    vol
    .
    191
    ,
    p
    .
    E179-E187
    .
  2. Fromentin, R., DaFonseca, S., Costiniuk, C. T., El-Far, M., Procopio, F. A., Hecht, F. M., Hoh, R., Deeks, S. G., Hazuda, D. J., Lewin, S. R., Routy, J.-P., Sékaly, R.-P. & Chomont, N.
    (2019)
    .
    PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals
    .
    Nature communications
    ,
    vol
    .
    10
    ,
    p
    .
    814
    .
  3. De Schryver, S., Mazer, B., Clarke, A., St Pierre, Y., Lejtneyi, D., Langlois, A., Torabi, B., Zhao, W. W., Chan, E. S., Baerg, I. & Ben-Shoshan, M.
    (2019)
    .
    Adverse events in oral immunotherapy for the desensitization of cow's milk allergy in children: a randomized controlled trial
    .
    The journal of allergy and clinical immunology. In practice
  4. Vinh, D. C.
    (2019)
    .
    The molecular immunology of human susceptibility to fungal diseases: lessons from single gene defects of immunity
    .
    Expert review of clinical immunology
  5. Legge, A., Kirkland, S., Rockwood, K., Andreou, P., Bae, S.-C., Gordon, C., Romero-Diaz, J., Sanchez-Guerrero, J., Wallace, D. J., Bernatsky, S., Clarke, A. E., Merrill, J. T., Ginzler, E. M., Fortin, P., Gladman, D. D., Urowitz, M. B., Bruce, I. N., Isenberg, D. A., Rahman, A., Alarcón, G. S., Petri, M., Khamashta, M. A., Dooley, M. A., Ramsey-Goldman, R., Manzi, S., Steinsson, K., Zoma, A. A., Aranow, C., Mackay, M., Ruiz-Irastorza, G., Lim, S. S., Inanc, M., van Vollenhoven, R. F., Jonsen, A., Nived, O., Ramos-Casals, M., Kamen, D. L., Kalunian, K. C., Jacobsen, S., Peschken, C. A., Askanase, A. & Hanly, J. G.
    (2019)
    .
    Evaluating the properties of a frailty index and its association with mortality risk among patients with systemic lupus erythematosus
    .
    Arthritis & rheumatology (Hoboken, N.J.)
More publications